Cargando…
Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes
Tumour‐draining lymph nodes (LNs) undergo massive remodelling including expansion of the lymphatic sinuses, a process that has been linked to lymphatic metastasis by creation of a pre‐metastatic niche. However, the signals leading to these changes have not been completely understood. Here, we found...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859913/ https://www.ncbi.nlm.nih.gov/pubmed/35188342 http://dx.doi.org/10.1002/jev2.12197 |
_version_ | 1784654557421240320 |
---|---|
author | Leary, Noelle Walser, Sarina He, Yuliang Cousin, Nikola Pereira, Paulo Gallo, Alessandro Collado‐Diaz, Victor Halin, Cornelia Garcia‐Silva, Susana Peinado, Hector Dieterich, Lothar C. |
author_facet | Leary, Noelle Walser, Sarina He, Yuliang Cousin, Nikola Pereira, Paulo Gallo, Alessandro Collado‐Diaz, Victor Halin, Cornelia Garcia‐Silva, Susana Peinado, Hector Dieterich, Lothar C. |
author_sort | Leary, Noelle |
collection | PubMed |
description | Tumour‐draining lymph nodes (LNs) undergo massive remodelling including expansion of the lymphatic sinuses, a process that has been linked to lymphatic metastasis by creation of a pre‐metastatic niche. However, the signals leading to these changes have not been completely understood. Here, we found that extracellular vesicles (EVs) derived from melanoma cells are rapidly transported by lymphatic vessels to draining LNs, where they selectively interact with lymphatic endothelial cells (LECs) as well as medullary sinus macrophages. Interestingly, uptake of melanoma EVs by LN‐resident LECs was partly dependent on lymphatic VCAM‐1 expression, and induced transcriptional changes as well as proliferation of those cells. Furthermore, melanoma EVs shuttled tumour antigens to LN LECs for cross‐presentation on MHC‐I, resulting in apoptosis induction in antigen‐specific CD8(+) T cells. In conclusion, our data identify EV‐mediated melanoma—LN LEC communication as a new pathway involved in tumour progression and tumour immune inhibition, suggesting that EV uptake or effector mechanisms in LECs might represent a new target for melanoma therapy. |
format | Online Article Text |
id | pubmed-8859913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88599132022-02-27 Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes Leary, Noelle Walser, Sarina He, Yuliang Cousin, Nikola Pereira, Paulo Gallo, Alessandro Collado‐Diaz, Victor Halin, Cornelia Garcia‐Silva, Susana Peinado, Hector Dieterich, Lothar C. J Extracell Vesicles Research Articles Tumour‐draining lymph nodes (LNs) undergo massive remodelling including expansion of the lymphatic sinuses, a process that has been linked to lymphatic metastasis by creation of a pre‐metastatic niche. However, the signals leading to these changes have not been completely understood. Here, we found that extracellular vesicles (EVs) derived from melanoma cells are rapidly transported by lymphatic vessels to draining LNs, where they selectively interact with lymphatic endothelial cells (LECs) as well as medullary sinus macrophages. Interestingly, uptake of melanoma EVs by LN‐resident LECs was partly dependent on lymphatic VCAM‐1 expression, and induced transcriptional changes as well as proliferation of those cells. Furthermore, melanoma EVs shuttled tumour antigens to LN LECs for cross‐presentation on MHC‐I, resulting in apoptosis induction in antigen‐specific CD8(+) T cells. In conclusion, our data identify EV‐mediated melanoma—LN LEC communication as a new pathway involved in tumour progression and tumour immune inhibition, suggesting that EV uptake or effector mechanisms in LECs might represent a new target for melanoma therapy. John Wiley and Sons Inc. 2022-02-21 2022-02 /pmc/articles/PMC8859913/ /pubmed/35188342 http://dx.doi.org/10.1002/jev2.12197 Text en © 2022 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Leary, Noelle Walser, Sarina He, Yuliang Cousin, Nikola Pereira, Paulo Gallo, Alessandro Collado‐Diaz, Victor Halin, Cornelia Garcia‐Silva, Susana Peinado, Hector Dieterich, Lothar C. Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title | Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title_full | Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title_fullStr | Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title_full_unstemmed | Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title_short | Melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
title_sort | melanoma‐derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859913/ https://www.ncbi.nlm.nih.gov/pubmed/35188342 http://dx.doi.org/10.1002/jev2.12197 |
work_keys_str_mv | AT learynoelle melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT walsersarina melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT heyuliang melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT cousinnikola melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT pereirapaulo melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT galloalessandro melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT colladodiazvictor melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT halincornelia melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT garciasilvasusana melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT peinadohector melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes AT dieterichlotharc melanomaderivedextracellularvesiclesmediatelymphaticremodellingandimpairtumourimmunityindraininglymphnodes |